To characterize hepatitis C virus (HCV) epidemiology in Pakistan and estimate the pooled
mean HCV antibody prevalence in different risk populations, we systematically reviewed all …

Summary Background The epidemiology of Chlamydia trachomatis in the Middle East and
north Africa is poorly understood. We aimed to provide a comprehensive epidemiological …

Introduction. Hemodialysis patients have the highest risk for developing hepatitis B virus
(HBV) and hepatitis C virus (HCV) than the general population. There is no study available …

Background With one in every 20 Pakistanis already infected, Pakistan has the second
largest number of hepatitis C virus (HCV) infections globally. The aim of this study was to …

The objective was to delineate hepatitis C virus (HCV) epidemiology in countries of Central
Asia (CA), specifically Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan. A …

Abstract Background and Aims This study aimed to assess the safety and efficacy of
sofosbuvir (SOF)‐based regimens in patients with moderate to severe renal impairment; a …

BACKGROUND The presence of hepatitis C virus (HCV) RNA in liver tissue or peripheral
blood mononuclear cells with no identified virus genome in the serum has been reported …

Expanding hepatitis C virus (HCV) treatment coverage is challenged by limited testing and
diagnosis. This study assessed the risk of exposure, for the Middle East and North Africa, by …

Infection with the hepatitis C virus (HCV) remains a considerable public health concern in
the Middle East and North Africa (MENA). The objectives of this study were to analyze the …

Summary Background The Middle East and North Africa (MENA) region is the most affected
by hepatitis C virus (HCV) infection globally. This study aimed to estimate HCV incidence …